Abonnement for 2 €

Sikre fra 2 euro

Financial Data API

Terminal Financial Data API

Inventiva Aktie News & Pressemeldungen

Inventiva Eulerpool Nyheter

Investition mit Weitblick: Inventiva stärkt Phase-3-Studie durch millionenschwere Finanzierung

Inventiva erhält Finanzspritze für Phase-III-Studie zu MASH-Medikament

1

1

Inventiva Aksje Nyheter

Inventiva blir fulgt av mange journalister og investorer over hele verden. De nyeste Inventiva nyhetene presenterer vi her.

·
Yahoo
Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
·
TipRanks
Inventiva Gains Positive Nod for Lanifibranor Trial
·
TipRanks
Inventiva announces DMC recommendation to continue NATiV3 trial as is
·
Yahoo
Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
·
Yahoo
Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data
·
TipRanks
Inventiva Secures €348 Million Financing, Reinforcing Buy Rating Amid Strategic Advancements
·
Thefly.com
Inventiva price target lowered by $1 at H.C. Wainwright, here's why
·
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
·
TipRanks
Inventiva S.A. Plans Significant Capital Raise
·
TipRanks
Inventiva’s 2024 Interim Financial Highlights and Prospects

1

2

1

2

Inventiva Aksje Pressemeldinger

Inventiva publiserer regelmessig meldinger som er relevante for investorer på selskapets nettside.

Gjør de beste investeringene i ditt liv

Sikre deg fra 2 euro